Neurosoft Bioelectronics

Curated by Signal

Provider of soft implantable electrodes for neurological disorders

Life Sciences Technologyneurosoft-bio.com

Overview

Provider of soft implantable electrodes for neurological disorders. The company offers its proprietary technology SOFT ECoG which is a subdural electrode made up of thin metal films of sub-micron thickness to achieve long-term bio-integration in the body, conforming to the static and dynamic mechanics of neural tissue. The company claims that the product is still under development and is not approved for human use.

Key facts

Founded: 2019
Headquarters: Geneva, Switzerland
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

3 products and services: Sign up to view

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

MOWA
Developer of lower limb orthosis system
Life Sciences TechnologySolothurn, Switzerland
Hi-D Imaging
Provider of clinical decision making solutions
Life Sciences TechnologyOpfikon, Switzerland
MIKAJAKI
Developer of eye health diagnostics products
Life Sciences TechnologyPlan les Ouates, Switzerland

About Neurosoft Bioelectronics

What does Neurosoft Bioelectronics do?

Provider of soft implantable electrodes for neurological disorders.

Where is Neurosoft Bioelectronics headquartered?

Neurosoft Bioelectronics is headquartered in Geneva, Switzerland.

When was Neurosoft Bioelectronics founded?

Neurosoft Bioelectronics was founded in 2019.

Which sector is Neurosoft Bioelectronics in?

Neurosoft Bioelectronics operates in Life Sciences Technology.

Who are Neurosoft Bioelectronics's competitors?

Companies similar to Neurosoft Bioelectronics include MOWA, Hi-D Imaging, and MIKAJAKI.